Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Tricaprilin in Mild to Moderate Alzheimer's Disease

ClinicalTrials.gov ID: NCT00142805

Public ClinicalTrials.gov record NCT00142805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 4:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety, Tolerability and Efficacy Study of Tricaprilin (AC-1202) Administered for Ninety Days in Subjects With Probable Alzheimer's Disease of Mild to Moderate Severity

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate, probable Alzheimer's disease.

Study identification

NCT ID
NCT00142805
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cerecin
Industry
Enrollment
152 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
50 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 3, 2004
Primary completion
Jun 28, 2006
Completion
Jan 6, 2007
Last update posted
Sep 20, 2020

2004 – 2007

United States locations

U.S. sites
25
U.S. states
7
U.S. cities
23
Facility City State ZIP Site status
21st Century Neurology, a division of Xenoscience Inc. Phoenix Arizona 85013
Comprehensive NeuroScience Cerritos California 90703
Pharmacology Research Institute Los Alamitos California 90720
Pharmacology Research Institute Newport Beach California 92660
Pharmacology Research Institute Northridge California 91324
The Southwest Institute for Clinical Research Rancho Mirage California 92270
Pharmacology Research Institute Riverside California 92506
Baumel-Eisner Neuromedical Institute Boca Raton Florida 33486
Meridien Research Brooksville Florida 34613
Baumel-Eisner Neuromedical Institute, Inc. Fort Lauderdale Florida 33321
Sunrise Clinical Research Hollywood Florida 33021
Comprehensive NeuroScience Melbourne Florida 32935
Baumel-Eisner Neuromedical Institute Miami Beach Florida 33154
Anchor Research Center Naples Florida 34102
Renstar Medical Research Ocala Florida 34471
Comprehensive NeuroScience St. Petersburg Florida 33702
Meridien Research St. Petersburg Florida 33709
Meridien Research Tampa Florida 33609
Radiant Research Chicago Illinois 60610
Multi-Specialty Research Associates of North Carolina Raleigh North Carolina 27609
Radiant Research Portland Oregon 97239
Radiant Research Dallas Texas 75231
Research Across America Dallas Texas 75234
Radiant Research San Antonio Texas 78229
Grayline Clinical Drug Trials Wichita Falls Texas 76309

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00142805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 20, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00142805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →